Latest News & Features
Americas
Pay-for-delay agreements, otherwise known as reverse settlements, stand at the intersection of intellectual property and competition law, but the clarity hoped for after Actavis has not yet arrived. LSIPR investigates. 1 June 2016
Big Pharma
Despite several major EU rulings on supplementary protection certificates, national IP offices and courts can form differing interpretations, and it seems that a unitary-style SPC right would be hard to create. LSIPR reports. 1 June 2016
Americas
In 2015 the US Federal Circuit resolved the biosimilars case of Amgen v Sandoz. But the parties did not stop there, meaning the Supreme Court could potentially review it. LSIPR looks at the consequences of a possible review. 31 May 2016
Americas
A firm advocate of ‘open innovation’, Novartis is setting aside rivalries and working on a number of projects to ensure patients get the best treatments as quickly as possible. LSIPR spoke to Graham Stuart of the company about some of the work. 31 May 2016
Americas
Thermo Fisher Scientific has announced that it will buy FEI, an electron microscopy company, for $4.2 billion. 31 May 2016
Americas
Teva and Spectrum Pharmaceuticals have settled a patent dispute over the generic version of Folotyn, a treatment for patients with relapsed or refractory peripheral T-cell lymphoma. 27 May 2016
Americas
Law firm McMillan has hired Stuart Kruger as a partner in the firm’s pharmaceuticals and biotechnology practice in Montreal. 26 May 2016
Americas
Each ‘patent dance’ dispute between biologics and biosimilars companies will present its own nuances in the process of solving the mystery, argue Lisa Pensabene and Daniel O'Boyle of O’Melveny & Myers. 26 May 2016
Americas
Egalet Corporation announced that it has reached an agreement with Purdue Pharma regarding the alleged patent infringements by Egalet and product licensor Acura Pharmaceuticals through Oxaydo tablets. 25 May 2016
Americas
Monsanto has rejected Bayer’s $62 billion buyout offer that would have created the world’s largest agricultural supplier, calling the bid “incomplete and financially inadequate”, but said it was open to negotiate further. 25 May 2016